- Home
- GTBP vs ATNF Comparison
GTBP vs ATNF Comparison
Compare GTBP & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- ATNF
- Stock Information
- Founded
- GTBP 1965
- ATNF 2016
- Country
- GTBP United States
- ATNF United States
- Employees
- GTBP N/A
- ATNF N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- GTBP Health Care
- ATNF Health Care
- Exchange
- GTBP Nasdaq
- ATNF Nasdaq
- Market Cap
- GTBP 6.8M
- ATNF 5.7M
- IPO Year
- GTBP N/A
- ATNF N/A
- Fundamental
- Price
- GTBP $2.39
- ATNF $1.56
- Analyst Decision
- GTBP Strong Buy
- ATNF
- Analyst Count
- GTBP 1
- ATNF 0
- Target Price
- GTBP $11.00
- ATNF N/A
- AVG Volume (30 Days)
- GTBP 1.3M
- ATNF 1.1M
- Earning Date
- GTBP 11-14-2024
- ATNF 02-13-2025
- Dividend Yield
- GTBP N/A
- ATNF N/A
- EPS Growth
- GTBP N/A
- ATNF N/A
- EPS
- GTBP N/A
- ATNF N/A
- Revenue
- GTBP N/A
- ATNF N/A
- Revenue This Year
- GTBP N/A
- ATNF N/A
- Revenue Next Year
- GTBP N/A
- ATNF $54.15
- P/E Ratio
- GTBP N/A
- ATNF N/A
- Revenue Growth
- GTBP N/A
- ATNF N/A
- 52 Week Low
- GTBP $1.72
- ATNF $1.16
- 52 Week High
- GTBP $10.66
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- GTBP 42.95
- ATNF 40.40
- Support Level
- GTBP $2.32
- ATNF $1.40
- Resistance Level
- GTBP $2.63
- ATNF $1.67
- Average True Range (ATR)
- GTBP 0.27
- ATNF 0.19
- MACD
- GTBP -0.05
- ATNF -0.00
- Stochastic Oscillator
- GTBP 33.00
- ATNF 13.22
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.